The prevalence of gestational diabetes mellitus (GDM) is increasing globally which is associated with various side effects for mothers and fetus. It seems that metabolomic profiling of the amino acids may be useful in early diagnosis of metabolic diseases. This study aimed to explore the association of the amino acids profiles with GDM.
Eighty three pregnant women with gestational age ≥25 weeks were randomly selected among pregnant women referred to prenatal care clinic in Arash hospital of Tehran, Iran. Women divided into three groups including 1) 25 pregnant women with normal glucose tolerance test, 2) 27 pregnant women with diabetes type 2 (T2D) (n: 27) and 3) 31 women with GDM (n: 31). Plasma levels of amino acids were measured by high performance liquid chromatography and were compared in three groups. Statistical analysis was performed using SPSS 16.
Compared with normal mothers, GDM mothers showed higher plasma concentrations of Arginine (P = 0.01), Glycine (P = 0.01) and Methionine (P = 0.04), whereas the pregnant women with T2D had higher plasma levels of Asparagine (P = 0.01), Tyrosine (P < 0.01), Valine (P < 0.01), Phenylalanine (P < 0.01), Glutamine (P < 0.01) and Isolucine (P < 0.01). The results of regression analyses confirmed the significantly elevated in plasma concentration of Asparagine (OR:3.64, CI 1.22–10.47), Threonine (OR:3.38, CI 1.39–8.25), Aspartic acid (OR:3.92, CI 1.19–12.91), Phenylalanine (OR:2.66, CI 1.01–6.94), Glutamine (OR:2.53, CI 1.02–6.26) and Arginine (OR:1.96, CI 1.02–3.76) after adjustment for gestational age and BMI in GDM mothers compared to normal ones.
Amino acids levels are associated with risk of GDM and diabetes mellitus. However further prospective studies are needed to clarify the role of different metabolites involved in mechanism of GDM.
Kim C. Gestational diabetes: risks, management, and treatment options. Int J Women’s health. 2010;2:339–51. CrossRef
Association AD. 2. Classification and diagnosis of diabetes. Diabetes Care. 2015;38(Supplement 1):S8–S16. CrossRef
Seshiah V, Das AK, Balaji V, Joshi SR, Parikh MN, Gupta S. Gestational diabetes mellitus--guidelines. J Assoc Physicians India. 2006;54:622–8. PubMed
Alavinia M, Etemad K, A M. Gestational diabetes mellitus in Iran- experience from the national diabetes program. Int J Pharm Healthc Mark. 2007;6(2):156–66.
Agarwal MM, Boulvain M, Coetzee E, Colagiuri S, Falavigna M, Hod M, et al. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: A world health organization guideline. Diabetes Res Clin Pract. 2014;103:341–63. CrossRef
Bentley-Lewis R, Huynh J, Xiong G, Lee H, Wenger J, Clish C, et al. Metabolomic profiling in the prediction of gestational diabetes mellitus. Diabetologia. 2015;58(6):1329–32.
Smirnakis KV, Plati A, Wolf M, Thadhani R, Ecker JL. Predicting gestational diabetes: choosing the optimal early serum marker. Am J Obstet Gynecol. 2007;196(4):410. e1–. e7.
She P, Van Horn C, Reid T, Hutson SM, Cooney RN, Lynch CJ. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol-Endocrinol Metabol. 2007;293(6):E1552–63. CrossRef
Pappa KI, Vlachos G, Theodora M, Roubelaki M, Angelidou K, Antsaklis A. Intermediate metabolism in association with the amino acid profile during the third trimester of normal pregnancy and diet-controlled gestational diabetes. Am J Obstet Gynecol. 2007;196(1):65.e1–.e5.
Kalhan SC. Protein metabolism in pregnancy. In: Cowett RM, ed. Principles of perinatal-neonatal metabolism. 2nd ed. New York: Springer; 1998. p. 207–20.
- Amino acid profiling in the gestational diabetes mellitus
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II